Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Angewandte Chemie (International Ed. in English)|April 25, 2000
The Catalytic Asymmetric Aldol ReactionMachajewski, WongChemistry & Biology|November 30, 2000
Directed evolution of D-2-keto-3-deoxy-6-phosphogluconate aldolase to new variants for the efficient synthesis of D- and L-sugarsS Fong, T D Machajewski, C C Mak, et al.The Journal of Organic Chemistry|August 16, 2003
One-pot synthesis of L-Fructose using coupled multienzyme systems based on rhamnulose-1-phosphate aldolaseDirk Franke, Timothy Machajewski, Che-Chang Hsu, et al.Journal of Clinical Medicine|June 12, 2026
Preliminary Quantitative MRI Assessment After Combined Posterior Endoscopic Cervical Discectomy and Foraminotomy: An Exploratory Retrospective Cohort StudyTomasz Sienkiel, Barbara Jasiewicz, Dominik Taterra, et al.Molecular Cancer Therapeutics|January 17, 2012
The novel oral Hsp90 inhibitor NVP-HSP990 exhibits potent and broad-spectrum antitumor activities in vitro and in vivoDaniel L Menezes, Pietro Taverna, Michael R Jensen, et al.Proceedings of the National Academy of Sciences of the United States of America|July 5, 2007
Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout miceUrvi Desai, E-Chiang Lee, Kyu Chung, et al.Journal of Medicinal Chemistry|July 16, 2019
Optimization and Mechanistic Characterization of Pyridopyrimidine Inhibitors of Bacterial Biotin CarboxylaseLogan D Andrews, Timothy R Kane, Paola Dozzo, et al.Antimicrobial Agents and Chemotherapy|August 28, 2019
Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosaKevin M Krause, Cat M Haglund, Christy Hebner, et al.ACS Medicinal Chemistry Letters|September 24, 2015
Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic MelanomaTeresa E Williams, Sharadha Subramanian, Joelle Verhagen, et al.Journal of Medicinal Chemistry|December 31, 2008
Design, structure-activity relationships and in vivo characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: a novel class of receptor tyrosine kinase inhibitorsPaul A Renhowe, Sabina Pecchi, Cynthia M Shafer, et al.Pageof 2